Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - IDENIX PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - IDENIX PHARMACEUTICALS INC | d299951d10k.htm |
| EX-23.1 - EXHIBIT 23.1 - IDENIX PHARMACEUTICALS INC | d299951dex231.htm |
| EX-31.2 - EXHIBIT 31.2 - IDENIX PHARMACEUTICALS INC | d299951dex312.htm |
| EX-32.1 - EXHIBIT 32.1 - IDENIX PHARMACEUTICALS INC | d299951dex321.htm |
| EX-31.1 - EXHIBIT 31.1 - IDENIX PHARMACEUTICALS INC | d299951dex311.htm |
| EX-10.12 - EXHIBIT 10.12 - IDENIX PHARMACEUTICALS INC | d299951dex1012.htm |
| EX-21.1 - EXHIBIT 21.1 - IDENIX PHARMACEUTICALS INC | d299951dex211.htm |
EXHIBIT 32.2
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Idenix Pharmaceuticals, Inc. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Daniella Beckman, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: March 6, 2012 | ||
| /s/ Daniella Beckman | ||
| Daniella Beckman | ||
| Chief Financial Officer | ||
A signed original of this written statement required by Section 906 has been provided to Idenix Pharmaceuticals, Inc. and will be retained by Idenix Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.